Reditux 500 (Rituximab 500 mg Injection) – Anti-CD20 Monoclonal Antibody

Reditux 500 is a high-quality biosimilar of Rituximab, containing 500 mg of the active ingredient per vial. It is a monoclonal antibody that targets CD20 proteins on B-cells, used in the treatment of:

• Non-Hodgkin’s Lymphoma (NHL)

• Chronic Lymphocytic Leukemia (CLL)

• Rheumatoid Arthritis (RA)

• Pemphigus Vulgaris

• Off-label uses (as prescribed)

Key Features:
✔ High Efficacy & Safety Profile
✔ Manufactured under GMP Standards
✔ Available for Wholesale & Export
✔ Cold Chain Shipping Available

Dosage: Administered via IV infusion under medical supervision

FAQ Section Reditux 500 (Rituximab 500 mg Injection)

1. What is Reditux 500 used for?
Reditux 500 (Rituximab 500 mg) is used to treat blood cancers (NHL, CLL), autoimmune disorders (RA, Pemphigus Vulgaris), and other CD20+ conditions.

2. How is Reditux 500 administered?
It is given as an intravenous (IV) infusion in a hospital or clinic under medical supervision.

3. What are the side effects of Reditux 500?
Common side effects include fever, chills, nausea, fatigue, and low blood cell counts. Severe reactions (allergies, infections) are rare but possible.

4. Is Reditux 500 a biosimilar?
Yes, it is a biosimilar to Rituximab, offering the same efficacy at a competitive price.

5. Can I buy Reditux 500 online?
Yes, Pharma-Dropshipper supplies Reditux 500 globally to hospitals, pharmacies, and licensed buyers.

6. What is the shelf life of Reditux 500?
Typically 24 months when stored at 2–8°C (refrigerated).